Laminar Pharma

Laminar Pharmaceuticals S.A. is a Spanish biotechnology company founded in 2006, dedicated to translational health research, rational design, and the development of drugs for treating cancer and other conditions. These drugs are in the form of synthetic fatty acids, considered "first-class health solutions," based on a novel technology called Melitherapy (MLT or Membrane Lipid Therapy). From the rational design of molecules to clinical trials prior to new drug approval, Laminar controls all processes through continuous investment in R&D and adherence to high-quality standards.